title: Sustained monomorphic ventricular tachycardia after adenosine infusion.
abstract: Adenosine is used as pharmacological treatment of the first choice for the termination of regular small complex tachycardia. Although it is considered safe in this context, several reports of short lasting proarrythmic effects have been described. We present a case of a sustained monomorphic ventricular tachycardia following adenosine infusion.
authors.forename: Martin
authors.initials: M
authors.lastname: Huemer
authors.forename: Leif-Hendrik
authors.initials: LH
authors.lastname: Boldt
authors.forename: Sascha
authors.initials: S
authors.lastname: Rolf
authors.forename: Daniela
authors.initials: D
authors.lastname: Blaschke
authors.forename: Abdul
authors.initials: A
authors.lastname: Parwani
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Haverkamp
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D007275:Injections, Intravenous; D013610:Tachycardia / Q000175:diagnosis / Q000188:drug therapy*; D017180:Tachycardia, Ventricular / Q000139:chemically induced* / Q000503:physiopathology*; D018879:Ventricular Premature Complexes / Q000139:chemically induced / Q000175:diagnosis
chemical_list: D000889:Anti-Arrhythmia Agents; D000241:Adenosine